FIGS Q1 2026: Stitching Together Revenue Momentum and Margin Discipline

Overview

FIGS, Inc. reported its first quarter of 2026 with a healthy top-line beat in year-over-year revenue growth and a margin story that seems to hold even as operating spending ticks higher in absolute terms. The company notes net revenues of $159.9 million, up 28.0% from a year ago, driven by both growth in its core Scrubwear line and a notable contribution from non-scrubwear offerings. Management also published a financial highlights presentation on the investor relations site, signaling a desire to control the narrative beyond the press release.

By the numbers

• Net revenues: $159.9 million, +28.0% YoY.
• Gross margin: 67.7%, up modestly year over year, aided by pricing and efficiency efforts, offset by tariffs and product mix shifts.
• Operating expenses: $103.8 million, +22.6% YoY; as a percentage of net revenues, down to 64.9% from 67.8% a year ago, reflecting fixed-cost leverage and lower stock-based compensation.
• Net income: $6.3 million; EPS (diluted) $0.03, versus a net loss in the prior-year period.
• Net income margin: 3.9%.
• Customer base: Surpassed 3 million active customers for the first time, underscoring accelerated growth.

Geography and product mix

Geographically, US net revenues were $131.6 million, up 24.1% YoY, while international net revenues reached $28.3 million, a robust 49.9% year-over-year increase. Product line contribution shows Scrubwear net revenues at $126.6 million (+27.2% YoY) and non-scrubwear net revenues at $33.3 million (+31.3% YoY). The mix and pricing actions continue to influence gross margin and cost structure in a way that improvement is more than offset by market-driven tariffs and shifting product mix.

Outlook and strategy

The company reiterated an increasing full-year 2026 outlook, signaling confidence in demand, pricing, and operating leverage. A separate investor materials deck emphasizes continued focus on revenue growth, product mix optimization, and efficiency initiatives intended to protect margins even as marketing investments persist for campaigns such as the 2026 Winter Olympics. The combination of stronger top-line growth and a lower operating-expense ratio as a share of revenue is a theme that bears watching as the year unfolds.

Implications for FIGS and peers

FIGS’ Q1 narrative blends durable growth in healthcare apparel with disciplined expense management. The revenue forecast implications hinge on sustained demand from both scrubwear and non-scrubwear lines, plus continued international expansion. The strong EPS signal—though not paired with a disclosed consensus figure in the release—coupled with a positive earnings surprise vibe due to margin expansion and an upgraded outlook, may set a constructive tone for sector peers facing similar cross-currents: tariff pressure, supply-chain resilience, and the challenges of shifting product mix in a highly competitive space.

Industry watchers will be watching for the durability of the 3 million+ active-customer milestone and whether the cost discipline can outpace inflationary stress from marketing and fulfillment costs. In short, FIGS offers a case study in turning brisk top-line momentum into a margin-friendly growth story—an attractive template for peers as hospital-adjacent demand remains robust and consumer-grade medical apparel increases in visibility across channels.

Analyst’s take in a page-turner wink

From a framework perspective, FIGS’ story reads like a classic growth company that has learned to swim in choppier waters without losing sight of the shore. The EPS line is small but meaningful, anchored by a net income gain that stamps credibility on profitability in a quarter where revenue expanded across geographies and lines. The absence of a televised “earnings surprise” narrative in the text doesn’t negate the impact of the margin improvement and the lifted revenue forecast.

More subtly, the commentary around tariffs and product mix hints at a structural question for consumer-oriented health-care apparel: how much pricing power and efficiency can be extracted when demand is sticky but competition is fierce? If FIGS can sustain its current run-rate on gross margin while growing international revenue at a faster pace, it could become a reference point for peers wrestling with similar tariffs and logistics costs. The market may reward this balance with a steadier multiple, even if the next quarter’s headlines lean more toward execution than drama.

Bottom line

FIGS’ first-quarter performance reinforces a narrative of revenue momentum paired with margin discipline, validated by a raised full-year outlook and a growing active-customer base. For investors focused on EPS, revenue forecast, and earnings surprises, FIGS provides a tangible read on how a growth company in a specialized apparel niche can translate scale into profits while navigating tariffs and mix-driven margin headwinds. Sector peers will likely scrutinize whether FIGS’ approach—pricing discipline, efficiency gains, and strategic marketing—can be replicated as demand stays resilient in healthcare-adjacent consumer segments.